Indiana SB0150 caps the cost of a 30-day supply of prescription insulin at $35 for insured individuals.
Indiana SB0150 mandates that insurers limit the out-of-pocket cost for a 30-day supply of prescription insulin to $35, regardless of the number of prescriptions or types of insulin. This cap applies to health insurance plans issued, delivered, amended, or renewed after June 30, 2026. Insurers may charge less than $35, but not more. The cap does not apply if it would disqualify the plan from being a high deductible health plan under federal law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.